Asia
The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak.
The focus is on containment, although a number of organizations and companies are beginning work on vaccines.
It was another busy week for clinical trial updates. Here’s a look.
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.
Three months after Sandoz announced it would acquire the Japanese business of Aspen Global Incorporated, a subsidiary of Aspen Pharmacare Holdings for $330 million, the deal has been completed.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s Movers & Shakers.
Trivitron Healthcare launches 10 new innovation driven products in Advanced Imaging modalities and Critical Care & Life Support segment, at Arab Health 2020 conference in Dubai.
China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured.
All three companies have invested millions in the facilities to expand their global footprint.
The U.S. Department of Justice has leveled more charges against members of the U.S. science community who have alleged ties to China.
PRESS RELEASES